| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Sodium phenylbutyrate |
| Brand | Pheburane® |
| Indication | As adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase. |
| Assessment Process | |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |